insulin aspart sanofi
sanofi winthrop industrie - inzulin aspart - diabetes mellitus - léky užívané při diabetu - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
kirsty (previously kixelle)
biosimilar collaborations ireland limited - inzulin aspart - diabetes mellitus - léky užívané při diabetu - kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
sitagliptin sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetes mellitus, typ 2 - léky užívané při diabetu - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
truvelog mix 30
sanofi winthrop industrie - inzulin aspart - diabetes mellitus - léky užívané při diabetu - truvelog mix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.
anau 100mg potahovaná tableta
heaton k.s., praha array - 41 monohydrÁt sitagliptin-hydrochloridu - potahovaná tableta - 100mg - sitagliptin
ansifora 100mg potahovaná tableta
vipharm s.a., ożarów mazowiecki array - 41 monohydrÁt sitagliptin-hydrochloridu - potahovaná tableta - 100mg - sitagliptin
ansifora 50mg potahovaná tableta
vipharm s.a., ożarów mazowiecki array - 41 monohydrÁt sitagliptin-hydrochloridu - potahovaná tableta - 50mg - sitagliptin
asigefort 50mg/1000mg potahovaná tableta
tad pharma gmbh, cuxhaven array - 17555 sitagliptin; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/1000mg - metformin a sitagliptin
asigefort 50mg/850mg potahovaná tableta
tad pharma gmbh, cuxhaven array - 17555 sitagliptin; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/850mg - metformin a sitagliptin
humulin m3 (30/70) cartridge 100iu/ml injekční suspenze v zásobní vložce
eli lilly Čr, s.r.o., praha array - 4960 lidskÝ insulin - injekční suspenze v zásobní vložce - 100iu/ml - lidskÝ insulin